Chronic Kidney Disease III: Interprofessional Care
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 23, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Samuel Mathis1, Victor S Sierpina2
1Department of Family Medicine, University of Texas Medical Branch, 301 University Blvd, Rt. 1123, Galveston, TX, 77555-1123, USA. semathis@utmb.edu.
Complementary and integrative medicine (CIM) offers potential in preventing, treating, and managing side effects of kidney cancer. Further research is needed to confirm the effectiveness of these therapies for kidney cancer patients.
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: